Comparing biomarkers as principal surrogate endpoints (Q28740935)

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3163011

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

17 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3163011

A Z-theorem with Estimated Nuisance Parameters and Correction Note for 'Weighted Likelihood for Semiparametric Models and Two-phase Stratified Samples, with Application to Cox Regression'

23 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3163011

Statistical identifiability and the surrogate endpoint problem, with application to vaccine trials

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3163011

A bayesian approach to surrogacy assessment using principal stratification in clinical trials

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3163011

A parametric ROC model-based approach for evaluating the predictiveness of continuous markers in case-control studies

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3163011

Mediation analysis with principal stratification

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3163011

Integrating the predictiveness of a marker with its performance as a classifier

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3163011

Evaluating the predictiveness of a continuous marker

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3163011

Augmented designs to assess immune response in vaccine trials

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3163011

Statistical evaluation of biomarkers as surrogate endpoints: a literature review

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3163011

Index for rating diagnostic tests

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3163011

Statistical challenges in the evaluation of surrogate endpoints in randomized trials

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3163011

Principal stratification in causal inference

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3163011

Estimating the proportion of treatment effect explained by a surrogate marker.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3163011

Surrogate end points in clinical trials: are we being misled?

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3163011

Surrogate endpoints in clinical trials: definition and operational criteria

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3163011

The validation of surrogate endpoints in meta-analyses of randomized experiments

3 June 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-0420.2011.01603.X

Meta-analysis for the evaluation of potential surrogate markers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-0420.2011.01603.X

Evaluating candidate principal surrogate endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-0420.2011.01603.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-0420.2011.01603.X

Counterfactual links to the proportion of treatment effect explained by a surrogate marker

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21517791

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Statistical validation of intermediate endpoints for chronic diseases

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21517791